View in EDS HTML Full Text PDF Full Text

Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy.

Saved in:
Bibliographic Details
Title: Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy.
Authors: Vázquez R; Preclinical Department, Early Drug Development Group (E2DG), Boulogne-Billancourt, France.; Center for Genomic Science of IIT@SEMM, Fondazione Istituto Italiano di Tecnologia (IIT), Milan, Italy., Riveiro ME; Preclinical Department, Early Drug Development Group (E2DG), Boulogne-Billancourt, France., Berenguer-Daizé C; Aix Marseille University, CNRS, INP, Institute of NeuroPhysiopathology, Marseille, France., O'Kane A; Discovery and Scientific Affairs Department, Fusion Antibodies plc., Belfast, United Kingdom., Gormley J; Discovery and Scientific Affairs Department, Fusion Antibodies plc., Belfast, United Kingdom., Touzelet O; Discovery and Scientific Affairs Department, Fusion Antibodies plc., Belfast, United Kingdom., Rezai K; Department of Radio-Pharmacology, Institute Curie-René Huguenin Hospital, Saint-Cloud, France., Bekradda M; Preclinical Department, Early Drug Development Group (E2DG), Boulogne-Billancourt, France., Ouafik L; Aix Marseille University, CNRS, INP, Institute of NeuroPhysiopathology, Marseille, France.; APHM, CHU Nord, Service de Transfert d'Oncologie Biologique, Marseille, France.
Source: Frontiers in oncology [Front Oncol] 2021 Jan 06; Vol. 10, pp. 589218. Date of Electronic Publication: 2021 Jan 06 (Print Publication: 2020).
Publication Type: Journal Article; Review
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2234-943X
DOI:10.3389/fonc.2020.589218